Access cutting-edge trichomonas vaginalis infection treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access trichomonas vaginalis infection specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related trichomonas vaginalis infection treatment provided free
This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
Sponsor: Tulane University
Check if you qualify for this trichomonas vaginalis infection clinical trial in Birmingham, AL
If you're searching for trichomonas vaginalis infection treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced trichomonas vaginalis infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.